SCHEMBL7062964

SCHEMBL7062964

Cc1ccc(S(=O)(=O)ON(N=Cc2ccc(Cl)c(F)c2)C(=N)N)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.38
ATM Q13315 1/20 0.37
ALDH1A1 P00352 11/20 0.36
MAPT P10636 8/20 0.36
KMT2A Q03164 6/20 0.36
MEN1 O00255 5/20 0.36
LMNA P02545 3/20 0.36
GAA P10253 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
RECQL P46063 1/20 0.34
PTGS2 P35354 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7064635 0.92 GFER (0.38) GFERATMALDH1A1MAPTKMT2A
SCHEMBL7062979 0.88 GFER (0.38) GFERATMALDH1A1MAPTKMT2A
SCHEMBL7065660 0.86 ALDH1A1 (0.39) GFERATMALDH1A1MAPTKMT2A
SCHEMBL7064580 0.85 GFER (0.48) GFERALDH1A1MAPTKMT2AMEN1
SCHEMBL7065388 0.84 ATM (0.38) GFERATMALDH1A1MAPTKMT2A
SCHEMBL7065198 0.82 ATM (0.45) GFERATMALDH1A1MAPTKMT2A
SCHEMBL7062408 0.81 ALDH1A1 (0.39) GFERATMALDH1A1MAPTKMT2A
SCHEMBL7062962 0.80 ALDH1A1 (0.39) GFERATMALDH1A1MAPTKMT2A
SCHEMBL7062956 0.80 ALDH1A1 (0.39) GFERATMALDH1A1MAPTKMT2A
SCHEMBL7065233 0.80 PTGS2 (0.50) GFERATMALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313461-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS Melacure Therapeutics AB (SE) 2003-05-28 EP disclosed
WO-2002011715-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS MELACURE THERAPEUTICS AB (SE) 2002-02-14 WO disclosed